enow.com Web Search

  1. Ad

    related to: blinatumomab price

Search results

  1. Results from the WOW.Com Content Network
  2. Blinatumomab - Wikipedia

    en.wikipedia.org/wiki/Blinatumomab

    When blinatumomab was approved, Amgen announced that the price for the drug would be US$178,000 per year, which made it the most expensive cancer drug on the market. Merck's pembrolizumab was priced at US$150,000 per year when it launched (in September 2014). [ 15 ]

  3. Biz Brief: Micromet Stock Rises on Cancer Drug Trial Results

    www.aol.com/2010/06/14/biz-brief-micromet-stock...

    Micromet (MITI) shares traded some 3.3% higher on Monday after the small-cap biotech announced that its lead product candidate blinatumomab (MT103) led to remission in almost four-fifths of ...

  4. Bi-specific T-cell engager - Wikipedia

    en.wikipedia.org/wiki/Bi-specific_T-cell_engager

    Blinatumomab links T cells with CD19 receptors found on the surface of B cells. The Food and Drug Administration (US) and the European Medicines Agency approved this therapy for adults with Philadelphia chromosome-negative relapsed or refractory acute lymphoblastic leukemia.

  5. List of drugs granted breakthrough therapy designation

    en.wikipedia.org/wiki/List_of_drugs_granted...

    Blinatumomab: Treatment of CD19-positive Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia (ALL) in the consolidation phase of multiphase chemotherapy in people aged one month of age and older [2] Budesonide: For twelve weeks of treatment in people aged eleven years of age and older with eosinophilic esophagitis [2]

  6. Tariff threats, drug pricing will be 2 key pharma issues ...

    www.aol.com/finance/tariff-threats-drug-pricing...

    "Lowering drug prices is a focus area for both Republicans and Democrats, and Chinese CDMOs [manufacturers] such as Wuxi Group play a key role as it helps the US pharma cut costs by 30-60%.

  7. Amgen (AMGN) Q4 2024 Earnings Call Transcript - AOL

    www.aol.com/finance/amgen-amgn-q4-2024-earnings...

    Moving forward, we expect less price erosion for Repatha with 2025 net price expected to decline by mid single digits or less. EVENITY sales increased 35% in 2024, reaching almost $1.6 billion in ...

  8. AOL

    search.aol.com

    The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.

  9. List of therapeutic monoclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/List_of_therapeutic...

    Therapeutic, diagnostic and preventive monoclonal antibodies are clones of a single parent cell. When used as drugs, the International Nonproprietary Names (INNs) end in -mab.

  1. Ad

    related to: blinatumomab price